Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids.
Seiffert M, Stilgenbauer S, Döhner H, Lichter P. Seiffert M, et al. Leukemia. 2007 Sep;21(9):1977-83. doi: 10.1038/sj.leu.2404863. Epub 2007 Jul 19. Leukemia. 2007. PMID: 17637809
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Farfsing A, Engel F, Seiffert M, Hartmann E, Ott G, Rosenwald A, Stilgenbauer S, Döhner H, Boutros M, Lichter P, Pscherer A. Farfsing A, et al. Leukemia. 2009 Nov;23(11):2018-26. doi: 10.1038/leu.2009.144. Epub 2009 Jul 30. Leukemia. 2009. PMID: 19641524
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.
Seiffert M, Schulz A, Ohl S, Döhner H, Stilgenbauer S, Lichter P. Seiffert M, et al. Blood. 2010 Nov 18;116(20):4223-30. doi: 10.1182/blood-2010-05-284505. Epub 2010 Jul 26. Blood. 2010. PMID: 20660791
Antiapoptotic function of charged multivesicular body protein 5: a potentially relevant gene in acute myeloid leukemia.
Shahmoradgoli M, Mannherz O, Engel F, Heck S, Krämer A, Seiffert M, Pscherer A, Lichter P. Shahmoradgoli M, et al. Int J Cancer. 2011 Jun 15;128(12):2865-71. doi: 10.1002/ijc.25632. Epub 2010 Oct 19. Int J Cancer. 2011. PMID: 20734392
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.
Schulz A, Toedt G, Zenz T, Stilgenbauer S, Lichter P, Seiffert M. Schulz A, et al. Haematologica. 2011 Mar;96(3):408-16. doi: 10.3324/haematol.2010.031377. Epub 2010 Dec 6. Haematologica. 2011. PMID: 21134984 Free PMC article.
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.
Seiffert M, Dietrich S, Jethwa A, Glimm H, Lichter P, Zenz T. Seiffert M, et al. Leuk Lymphoma. 2012 Jun;53(6):1023-31. doi: 10.3109/10428194.2011.631638. Epub 2011 Dec 6. Leuk Lymphoma. 2012. PMID: 22023519 Review.
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells.
Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, Döhner H, Stilgenbauer S, Pscherer A, Lichter P, Seiffert M. Kovaleva V, et al. Cancer Res. 2012 Apr 1;72(7):1763-72. doi: 10.1158/0008-5472.CAN-11-3671. Epub 2012 Feb 20. Cancer Res. 2012. PMID: 22350415
Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment.
Schulz A, Dürr C, Zenz T, Döhner H, Stilgenbauer S, Lichter P, Seiffert M. Schulz A, et al. Blood. 2013 Mar 28;121(13):2503-11. doi: 10.1182/blood-2012-08-447664. Epub 2013 Jan 24. Blood. 2013. PMID: 23349394
Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.
Meier J, Hovestadt V, Zapatka M, Pscherer A, Lichter P, Seiffert M. Meier J, et al. RNA Biol. 2013 Jun;10(6):1018-29. doi: 10.4161/rna.24553. Epub 2013 Apr 15. RNA Biol. 2013. PMID: 23673373 Free PMC article.
Extracellular vesicles in chronic lymphocytic leukemia.
Haderk F, Hanna B, Richter K, Schnölzer M, Zenz T, Stilgenbauer S, Lichter P, Seiffert M. Haderk F, et al. Leuk Lymphoma. 2013 Aug;54(8):1826-30. doi: 10.3109/10428194.2013.796052. Leuk Lymphoma. 2013. PMID: 23848063
146 results
Jump to page